TLPH FY 2023 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$651,000

Gross Profit

-$5M-751.9% margin

Operating Income

-$17M-2594.3% margin

Net Income

-$18M-2826.0% margin

EPS (Diluted)

$-1.29

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$20M

Total Liabilities

$6M

Stockholders' Equity

$14M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$651,000	$0	—
Gross Profit	-$5M	-$2M	-197.2%
Operating Income	-$17M	-$20M	+17.0%
Net Income	-$18M	$43M	-143.3%